The liver is an organ that quietly works behind the scenes every day. It filters waste, produces proteins and bile, and helps break down toxins in the body. The concerning part is that early liver damage often causes no warning signs, meaning many people may not realize that their liver is being affected by a silent viral infection.
Hepatitis A and hepatitis B are important causes of liver disease that can be prevented through vaccination. According to the World Health Organization, approximately 254 million people worldwide are living with chronic hepatitis B, and many of them are unaware that they carry the virus. Hepatitis A also continues to circulate in many regions, particularly in areas where sanitation systems remain inadequate.
This article provides a comprehensive overview of hepatitis A and hepatitis B, including the differences between the two infections, how the combined vaccine works, who should receive it, whether immunity testing is recommended before vaccination, and how to prepare properly before receiving the vaccine.
What Are Hepatitis A and Hepatitis B, and What Causes Them?
What Is Hepatitis A, and What Causes It?
Hepatitis A is an infectious liver disease caused by the hepatitis A virus, or HAV. It is primarily transmitted through food or water contaminated with the feces of an infected person, as well as through close or direct contact with someone carrying the virus.
HAV is relatively resistant in the environment and may survive in water or food that has not been adequately heated. Symptoms usually develop around two to six weeks after exposure. Common symptoms include fever, nausea, vomiting, abdominal pain in the upper-right side of the abdomen, yellowing of the skin, and yellowing of the eyes, also known as jaundice.
One of the clearest differences between hepatitis A and hepatitis B is that hepatitis A generally causes an acute infection that resolves on its own in most people. It does not develop into a chronic infection. However, older adults and people with existing liver disease may experience more severe symptoms and may take longer to recover.
According to the World Health Organization, approximately 1% of hepatitis A cases may progress to acute liver failure, a potentially life-threatening condition.
What Is Hepatitis B, and What Causes It?
Hepatitis B is an infectious liver disease caused by the hepatitis B virus, or HBV. Compared with hepatitis A, HBV has a greater potential to cause severe and chronic liver disease.
HBV is mainly transmitted through three routes:
- Exposure to infected blood or bodily fluids, such as sharing needles or injection equipment, receiving tattoos, body piercings, or acupuncture in facilities that do not follow proper hygiene standards, or receiving unscreened blood or blood products.
- Sexual transmission, particularly through unprotected sexual contact with a person who has HBV.
- Mother-to-child transmission, especially during childbirth or shortly after birth.
Most adults who become infected with HBV are able to clear the virus naturally. However, approximately 5%–10% develop chronic infection. In contrast, up to 90% of infants infected by their mothers may develop chronic hepatitis B.
People with chronic HBV infection have an increased long-term risk of liver cirrhosis and hepatocellular carcinoma, the most common form of primary liver cancer.
What Is the Difference Between Hepatitis A and Hepatitis B?
Although both infections affect the liver, hepatitis A and hepatitis B differ significantly in their routes of transmission, disease progression, and long-term health risks.
Comparison Table: Hepatitis A vs. Hepatitis B
| Characteristic | Hepatitis A (HAV) | Hepatitis B (HBV) |
|---|---|---|
| Route of transmission | Contaminated food, water, or fecal matter | Blood, bodily fluids, sexual contact, and mother-to-child transmission |
| Incubation period | 2-6 weeks | 1-6 months |
| Disease course | Acute and usually self-limiting | May be acute or chronic |
| Risk of chronic infection | None | Approximately 5%-10% in adults and up to 90% in infants |
| Long-term complications | Uncommon; acute liver failure may occur in high-risk groups | Liver cirrhosis and liver cancer |
| Important blood tests | Anti-HAV IgM for acute infection and Anti-HAV IgG for immunity | HBsAg, Anti-HBs, and Anti-HBc |
| Available vaccine | Hepatitis A vaccine | Hepatitis B vaccine |
Why Is It Important to Prevent Hepatitis A and Hepatitis B?
Preventing hepatitis A and hepatitis B is important for different reasons.
For hepatitis A, infection can cause severe illness that may require a person to stop working for several weeks. In people with pre-existing chronic liver disease, hepatitis A infection may trigger acute liver failure and carry a higher risk of serious complications or death.
The danger of hepatitis B lies in its silent, chronic progression. Many people with chronic hepatitis B do not know that they are infected until substantial liver damage has already occurred.
According to the Thai Association for the Study of the Liver, Thailand continues to have a moderate-to-high prevalence of hepatitis B, and chronic HBV infection remains one of the country’s major causes of liver cancer.
One Combined Vaccine for Protection Against Two Hepatitis Viruses
The combined hepatitis A and B vaccine is designed to stimulate immunity against both hepatitis A and hepatitis B within a single vaccination series.
A well-known vaccine in this category is Twinrix. It contains inactivated hepatitis A virus together with recombinant hepatitis B surface antigen, or HBsAg. These components work together to stimulate the immune system to produce antibodies against both viruses.
According to the Centers for Disease Control and Prevention, the combined hepatitis A and B vaccine is approved for use in people aged 18 years and older and provides protection comparable to receiving the two vaccines separately.
How Is the Combined Vaccine Different from Separate Vaccines?
The choice between a combined vaccine and separate vaccines depends on several factors, including previous vaccination history, immunity test results, and the individual’s convenience.
The main advantage of the combined vaccine is that it reduces the number of separate injections and may reduce the number of clinic visits. It is especially suitable for people who do not have immunity to either hepatitis A or hepatitis B and wish to develop protection against both infections within one vaccination plan.
Separate vaccines may be more appropriate in certain situations.
For example, if a person already has adequate immunity to hepatitis B, confirmed through an Anti-HBs test, but has never received a hepatitis A vaccine, they may only need the hepatitis A vaccine.
Similarly, if a person already has immunity to hepatitis A but lacks immunity to hepatitis B, a separate hepatitis B vaccine may be more suitable.
Blood testing before vaccination can therefore be useful in choosing the most appropriate and cost-effective vaccination plan for each person.
What Does the Combined Hepatitis A and B Vaccine Protect Against?
Reducing the Risk of Hepatitis A
The hepatitis A vaccine is highly effective in preventing infection. According to the CDC, completing the hepatitis A vaccination series provides a high level of protection and may offer long-term immunity.
Protection against hepatitis A is particularly important for people traveling to high-risk countries, individuals with chronic liver disease, and people with weakened immune systems, as these groups may be more likely to develop severe illness if infected.
Reducing the Risk of Hepatitis B
The hepatitis B vaccine is one of the most effective vaccines currently available.
Research published in medical journals, including The Lancet, has shown that hepatitis B vaccination stimulates protective antibody production in most vaccine recipients. The World Health Organization also confirms that hepatitis B vaccination helps prevent HBV infection and reduces the risk of HBV-related liver cancer.
According to CDC recommendations, hepatitis B vaccination is recommended for all adults aged 19–59 years. It is also recommended for adults aged 60 years and older who have risk factors, as well as for those who wish to protect themselves from infection.
Reducing the Long-Term Risk of Liver Disease
One of the most important long-term benefits of the combined hepatitis A and B vaccine is the reduction in risk of chronic liver disease, liver cirrhosis, and liver cancer associated with hepatitis B infection.
The World Health Organization recognizes the hepatitis B vaccine as an important tool for reducing the global burden of liver cancer. It is considered the world’s first vaccine shown to prevent cancer at the population level.
Standard Three-Dose Schedule
The standard adult schedule for a combined hepatitis A and B vaccine such as Twinrix consists of three doses:
- Dose 1: On the day the vaccination series begins, or month 0
- Dose 2: One month after the first dose, or month 1
- Dose 3: Six months after the first dose, or month 6
Completing all three doses according to schedule allows the body to develop a more complete and long-lasting immune response against both viruses.
Combined Hepatitis A and B Vaccine Schedule
| Schedule | Dose 1 | Dose 2 | Dose 3 | Dose 4 booster | Notes |
|---|---|---|---|---|---|
| Standard schedule | Day 0 | Month 1 | Month 6 | Not generally required | Suitable for most adults |
| Accelerated schedule | Day 0 | Day 7 | Day 21-30 | Month 12 | May be considered for urgent travel |
An Accelerated Schedule May Be Considered for Some Travelers
For people with limited preparation time, such as those planning to travel soon, a doctor may consider an accelerated four-dose schedule.
This schedule generally consists of:
- First dose on day 0
- Second dose on day 7
- Third dose on day 21–30
- Booster dose at month 12
The accelerated schedule helps the body develop protection more quickly. However, the immune response before travel may not be as complete as that achieved through the standard schedule.
The choice of schedule should be based on medical assessment and the individual’s specific level of risk.
Why Completing the Vaccination Schedule Matters
If a person misses a scheduled dose or receives the next dose later than planned, they should not restart the entire vaccination series without medical advice.
In many cases, the next dose can simply be given when possible without starting again from the first dose. A doctor should assess the most appropriate timing for the remaining doses.
Who Should Receive the Combined Hepatitis A and B Vaccine?
People Who Want Protection Against Both Hepatitis A and Hepatitis B
The combined vaccine may be suitable for people who have never received hepatitis A or hepatitis B vaccination or who are unsure whether they have immunity.
A healthcare professional should review the person’s previous vaccination history. Blood testing may also be considered in certain cases to avoid unnecessary repeat vaccination.
Frequent Travelers and People Traveling to High-Risk Areas
People traveling to countries or regions with a high prevalence of viral hepatitis may benefit from vaccination. These may include parts of Asia, Africa, Central America, South America, and areas with inadequate sanitation.
Travelers should consult a doctor early enough to complete an appropriate vaccination plan before departure.
The CDC’s Advisory Committee on Immunization Practices recommends that people traveling to areas with a high risk of hepatitis A receive vaccination before travel. Ideally, the vaccine should be given at least two weeks before departure to allow time for the immune system to respond.
Healthcare Personnel and People Who May Be Exposed to Blood
Healthcare workers, clinic staff, laboratory personnel, rescue workers, tattoo artists, dental professionals, and people whose work may involve exposure to blood or bodily fluids should have adequate protection against hepatitis B.
Depending on their immunity and vaccination history, these individuals may receive either the combined vaccine or separate vaccines based on medical advice.
The European Association for the Study of the Liver recommends that healthcare personnel have adequate immunity against hepatitis B. Anti-HBs testing may be performed after the full vaccination series to confirm that sufficient immunity has developed.
People with Behavioral or Medical Risk Factors
People with certain behavioral or exposure risks should consult a doctor about vaccination as soon as possible.
Risk factors may include:
- Having multiple sexual partners
- Having unprotected sexual contact
- Sharing needles or injection equipment
- Receiving tattoos or body piercings in facilities that do not meet proper hygiene standards
- Living with or having close contact with someone who has chronic hepatitis B
Research published in the Journal of Hepatology indicates that vaccination among high-risk populations is cost-effective from a public-health perspective and can reduce both infection rates and the long-term burden of liver disease.
People with Liver Disease or an Increased Risk of Liver Disease
People with chronic liver disease, fatty liver disease, regular alcohol consumption, or other risk factors for liver inflammation should consult a doctor before vaccination.
Because their liver may already be vulnerable, an additional viral hepatitis infection could cause more severe illness or lead to rapid deterioration.
According to EASL guidance, hepatitis A vaccination is particularly important for people with chronic liver disease because superimposed HAV infection may carry a substantially higher risk of liver failure than in the general population.
Hepatitis B Blood Testing May Be Appropriate for Certain Groups
People who are unsure whether they have previously been infected with hepatitis B or have already received hepatitis B vaccination may consider blood testing before beginning the vaccination series.
Relevant tests include:
- HBsAg, or hepatitis B surface antigen: Indicates whether a person currently has HBV infection.
- Anti-HBs, or antibody to hepatitis B surface antigen: Indicates whether protective immunity is present following vaccination or previous infection.
- Anti-HBc, or antibody to hepatitis B core antigen: Indicates whether a person has previously been exposed to HBV.
According to the CDC, pre-vaccination testing should not become a barrier that delays vaccination, particularly in high-risk individuals. However, testing may help doctors plan a more appropriate vaccination strategy in certain groups.
People Who Already Have Immunity May Not Need the Full Combined Series
If blood testing confirms an adequate Anti-HBs level or shows that a person has already completed a hepatitis B vaccination series, a doctor may determine that the hepatitis B component does not need to be repeated.
In this situation, the person may be advised to receive a separate hepatitis A vaccine instead of the full combined vaccination series.
Previous Vaccination History Should Be Reported
Before receiving the combined vaccine, patients should tell their doctor whether they have previously received hepatitis A or hepatitis B vaccination, how many doses they received, and when the most recent dose was given.
This information helps healthcare professionals select the most appropriate plan and avoid unnecessary repeat vaccination.
How Should You Prepare Before Receiving the Combined Hepatitis A and B Vaccine?
Provide a Complete Medical History
Before receiving any vaccine, patients should inform their healthcare provider about relevant health information, including any underlying medical conditions—particularly liver disease or immune system disorders—current medications, any history of allergic reactions to vaccines or vaccine ingredients, and whether they are pregnant or breastfeeding. This information may affect the assessment of whether vaccination is appropriate and which type of vaccine should be administered.
Report Previous Hepatitis Vaccinations
Patients should inform the healthcare provider whether they have previously received hepatitis A or hepatitis B vaccines, how many doses they received, and when the last dose was given.
Some people may already have sufficient immunity or may only need a vaccine against one type of hepatitis rather than the combined vaccine.
Consider Blood Testing in Certain Situations
People who are unsure whether they have previously been infected with hepatitis B or have developed immunity may consider blood tests such as HBsAg, Anti-HBs, and Anti-HBc. These tests can help assess current infection status and immunity before a vaccination plan is selected.
Explain Your Risks and Reasons for Vaccination
Patients should inform their doctor if they have specific risk factors that are the reason for seeking vaccination, such as traveling to high-risk areas, working in occupations with potential exposure to blood, having a sexual partner or close household contact with hepatitis B infection, living with chronic liver disease, or being unsure of their immunity status. Providing this information enables the doctor to recommend the most appropriate vaccination plan based on the individual’s risk profile.
Postpone Vaccination If You Have a High Fever or Acute Illness
People with a high fever, significant fatigue, an acute infection, or severe illness may be advised to postpone vaccination until their condition improves. A doctor should assess whether the person is physically ready to receive the vaccine.
Rest Well and Eat Normally
Before and on the day of vaccination, patients should get sufficient rest, eat normally, and drink an appropriate amount of water. Fasting before vaccination is not recommended because it may increase the risk of dizziness, faintness, or fatigue after the injection.
Bring Previous Vaccination Records or Blood Test Results
Patients should bring any vaccination booklets, vaccination certificates, or blood test results related to hepatitis. These records can help the medical team determine whether the combined vaccine, a separate vaccine, or no additional vaccination is needed.
Side Effects of the Combined Hepatitis A and B Vaccine
Common Side Effects
Common side effects following the combined hepatitis A and B vaccine are generally mild and usually resolve on their own within 1–3 days. These may include pain, swelling, or redness at the injection site, headache, fatigue, low-grade fever, nausea, or muscle aches. These reactions are normal signs that the immune system is responding to the vaccine and typically do not require any specific treatment.
Unusual Symptoms That Require Urgent Medical Attention
Although severe reactions are extremely rare, patients should seek immediate medical attention if they experience any of the following symptoms after vaccination: difficulty breathing, swelling of the face or lips, widespread hives, severe or unusual dizziness, or a high fever. These symptoms may indicate a severe allergic reaction (anaphylaxis), which requires prompt medical treatment. For this reason, most healthcare facilities recommend that patients remain under observation for 15–30 minutes after receiving the vaccine.
Frequently Asked Questions About the Combined Hepatitis A and B Vaccine
Is the Combined Hepatitis A and B Vaccine Suitable for Children?
Direct answer: Some combined hepatitis A and B vaccines, such as Twinrix, are indicated only for individuals aged 18 years and older. Therefore, children and adolescents should be evaluated by a doctor to determine the appropriate vaccine type, dosage, and need based on their age. In many cases, separate hepatitis A and hepatitis B vaccines formulated specifically for pediatric use may be recommended.
If I Have Already Received the Hepatitis B Vaccine, Do I Still Need the Combined Vaccine?
Direct answer: If you have completed the hepatitis B vaccination series and have adequate immunity, you generally do not need the full combined vaccination series. A doctor may recommend a separate hepatitis A vaccine instead. An Anti-HBs test may be considered before making this decision to confirm whether protective hepatitis B immunity is still present.
Does the Combined Vaccine Protect Against Hepatitis C?
Direct answer: No. The combined hepatitis A and B vaccine protects only against the hepatitis A virus (HAV) and hepatitis B virus (HBV). There is currently no approved vaccine available to prevent hepatitis C virus (HCV) infection. Prevention of HCV focuses on reducing the risk of exposure to infected blood or contaminated equipment, as well as screening individuals who are at increased risk of infection.
Is Immunity Testing Required After Vaccination?
Direct answer: Routine post-vaccination testing is not necessary for everyone. However, Anti-HBs testing after completing the vaccination series may be recommended for healthcare workers, people with weakened immune systems, spouses or sexual partners of individuals with HBV infection, and those at high risk of occupational or repeated exposure. Testing helps confirm that the body has developed adequate protective immunity.
Can People with Chronic Liver Disease Receive the Combined Vaccine?
Direct answer: People with chronic liver disease, such as liver cirrhosis or fatty liver disease, can generally receive the combined vaccine. Vaccination is especially important in this group because an additional viral hepatitis infection may rapidly worsen existing liver damage. However, individuals with chronic liver disease should always consult their treating physician before receiving the vaccine.
Is the Combined Hepatitis A and B Vaccine Safe During Pregnancy?
Direct answer: Currently, data on the use of the combined hepatitis A and B vaccine during pregnancy are limited. In general, doctors assess the potential benefits and risks on an individual basis. Monovalent hepatitis B vaccines have been used safely in pregnant women at high risk of infection. Pregnant women considering vaccination should consult both their obstetrician and their healthcare provider before making a decision.
How Long Does Protection from the Combined Vaccine Last?
Direct answer: After completing the standard three-dose schedule, protection against hepatitis A is expected to last for several decades. For hepatitis B, individuals who achieve an adequate immune response (Anti-HBs ≥ 10 mIU/mL) are expected to remain protected for 20 years or longer in most cases. According to the World Health Organization (WHO), booster doses are generally not recommended for healthy individuals who have completed the full vaccination series and have normal immune function.
Quick Reference
| Question | Answer |
|---|---|
| Common combined vaccine used in adults | Twinrix, containing HAV and HBV components |
| Standard number of doses | 3 doses at months 0, 1, and 6 |
| Accelerated travel schedule | 4 doses on days 0, 7, and 21-30, with a booster at month 12 |
| Recommended age for the adult combined formulation | 18 years and older |
| Is blood testing required beforehand? | Recommended for certain groups; tests may include HBsAg, Anti-HBs, and Anti-HBc |
| Does it protect against hepatitis C? | No. Prevention focuses on reducing exposure risks |
| Common side effects | Injection-site pain, fatigue, and low-grade fever, usually resolving within 1-3 days |
| Should you consult a doctor first? | Yes. Medical consultation is recommended before vaccination |
Receive the Combined Hepatitis A and B Vaccine for Long-Term Liver Protection
Proactive Protection for Working Adults and Travelers
The combined hepatitis A and B vaccine is a convenient and effective option for people who want protection against both types of viral hepatitis within one vaccination plan.
It may be particularly suitable for frequent travelers, healthcare personnel, and people who are unsure whether they already have immunity.
The liver works quietly without showing how hard it is working. By the time liver-related symptoms appear, damage may already have accumulated for some time.
Vaccination is therefore a way to protect the liver before disease occurs, rather than waiting to treat the consequences after infection develops.
Consult a Doctor for an Individual Vaccination Plan
Before receiving the vaccine, patients should have a doctor assess their age, overall health, existing medical conditions, previous vaccination history, relevant blood test results, and individual risk factors.
This assessment helps determine the most appropriate vaccine type and vaccination schedule for safe and effective protection.
PSK Clinic, a sexual health clinic in Lat Phrao, Bangkok, provides hepatitis A and B vaccination services through a team of specialist doctors.
The clinic offers pre-vaccination consultations, assessment of whether blood testing is needed, and post-vaccination care in a private and non-judgmental environment.
To make an appointment, contact:
LINE: @pskclinic, Telephone: 095-049-4142
